/Companies

Arthex Biotech

6 known investors

Find your way into Arthex Biotech

Each arrow is one introduction. Sign up to fill in the first one.

9 people can intro you to Beatriz

Ask Markus Dietrich to introduce you to Beatriz Llamusí

You →Markus · together at Arthex Biotech →Beatriz

Sign up to find every way you can get introduced to Arthex Biotech

  • Your email: who you already know at Arthex Biotech, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Arthex Biotech team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs. The company focuses on microRNA-based therapeutic interventions.

Founders & leadership

BLBeatriz Llamusí
Beatriz LlamusíChief Scientific Officer & Co-FounderBeatriz Llamusí holds a Ph.D. in Biochemistry from the University Miguel Hernández and spent 13 years as a postdoctoral researcher in the Department of Genetics investigating rare neuromuscular diseases. She co-founded Arthex Biotech in 2019 to develop antisense RNA therapeutics and served as CEO until 2023, when she transitioned to Chief Scientific Officer.

Investors · 6

Frequently asked questions

What does Arthex Biotech do?
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs. The company focuses on microRNA-based therapeutic interventions.
Who founded Arthex Biotech?
Arthex Biotech was founded by Beatriz Llamusí.
Who are Arthex Biotech's investors?
Arthex Biotech's investors include Hadean Ventures, Sound Bioventures, Bpifrance, Columbus Venture Partners, AdBio partners, Invivo Capital Partners.